VC-backed Korro Bio appoints CEO

Korro Bio, a developer of single-base RNA editing therapies, has named Dr. Ram Aiyar as CEO.

10 November 2020•3 mins read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.

Healthcare Human Resources Briefs